HomeCompareVPAHF vs PM

VPAHF vs PM: Dividend Comparison 2026

VPAHF yields 270.27% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPAHF wins by $759.38M in total portfolio value
10 years
VPAHF
VPAHF
● Live price
270.27%
Share price
$0.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$759.43M
Annual income
$439,524,286.02
Full VPAHF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — VPAHF vs PM

📍 VPAHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPAHFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPAHF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VPAHF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPAHF
Annual income on $10K today (after 15% tax)
$22,972.97/yr
After 10yr DRIP, annual income (after tax)
$373,595,643.12/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, VPAHF beats the other by $373,593,524.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPAHF + PM for your $10,000?

VPAHF: 50%PM: 50%
100% PM50/50100% VPAHF
Portfolio after 10yr
$379.74M
Annual income
$219,763,389.02/yr
Blended yield
57.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

VPAHF
No analyst data
Altman Z
2.9
Piotroski
3/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPAHF buys
0
PM buys
0
No recent congressional trades found for VPAHF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPAHFPM
Forward yield270.27%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$759.43M$49.6K
Annual income after 10y$439,524,286.02$2,492.02
Total dividends collected$726.21M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VPAHF vs PM ($10,000, DRIP)

YearVPAHF PortfolioVPAHF Income/yrPM PortfolioPM Income/yrGap
1← crossover$37,727$27,027.03$11,648$408.29+$26.1KVPAHF
2$135,662$95,294.33$13,589$495.90+$122.1KVPAHF
3$465,409$320,250.45$15,877$603.21+$449.5KVPAHF
4$1,524,778$1,026,790.34$18,580$734.88+$1.51MVPAHF
5$4,775,420$3,143,907.74$21,781$896.75+$4.75MVPAHF
6$14,311,885$9,202,185.51$25,578$1,096.12+$14.29MVPAHF
7$41,088,348$25,774,630.79$30,092$1,342.17+$41.06MVPAHF
8$113,120,635$69,156,102.86$35,470$1,646.46+$113.09MVPAHF
9$298,977,565$177,938,485.31$41,892$2,023.58+$298.94MVPAHF
10$759,430,280$439,524,286.02$49,578$2,492.02+$759.38MVPAHF

VPAHF vs PM: Complete Analysis 2026

VPAHFStock

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Full VPAHF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this VPAHF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPAHF vs SCHDVPAHF vs JEPIVPAHF vs OVPAHF vs KOVPAHF vs MAINVPAHF vs MOVPAHF vs BTIVPAHF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.